AI failed to deliver on its promise in the 1970s and 1980s, but now the situation is fundamentally different, and the biopharma industry could be set to transform because of it.
from Forbes Real Time http://www.forbes.com/sites/forbestechcouncil/2017/08/03/artificial-intelligence-in-drug-discovery-a-bubble-or-a-revolutionary-transformation/
via IFTTT
No comments:
Post a Comment